Microbion to Present New Data Demonstrating that Pravibismane Disrupts Bacterial Bioenergetics at ASM Microbe 2023

Pravibismane is the first of a new class of drugs with broad-spectrum potency against a wide range of pathogens Poster presentation will highlight the results of a gene knockdown study suggesting pravibismane’s mechanism of action impacts bacterial bioenergetics and fatty acid…

No Comments

No comments yet.

Sorry, the comment form is closed at this time.